17/01/2022
Therapeutic Goods Administration - TGA recognises the Gamaleya Institute vaccine (Sputnik V, Russian Federation) for international travel to Australia.
Last week the TGA obtained additional information demonstrating this vaccine provides protection and potentially reduces the likelihood that an incoming traveller would transmit COVID-19 infection to others while in Australia or become acutely unwell due to COVID-19. The supporting information was based on published studies provided to the TGA by the Russian Government with the assistance of the Australian embassy in Moscow.
The recognition of Sputnik will expand options for the return of international students, travel of skilled and unskilled workers to Australia, and travel by business people and elite sports people to our country.
The TGA determined that the two dose course of the Gamaleya Institute vaccine (Sputnik V, Russian Federation) would be 'recognised' for the purpose of establishing a traveller's vaccination status.